The role of the viral glycoprotein in HIV-1 persistence. (Q33538298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

The role of the viral glycoprotein in HIV-1 persistence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Peter Balfe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Balfe P

series ordinal

2

1 reference

27 July 2017

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

63-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Evaluation of testing algorithms following the use of combination HIV-1/HIV-2 EIA for screening purposes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

1 reference

7 January 2021

Antigenic Diversity Thresholds and the Development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

How HIV Defeats the Immune System

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Increasing genotypic and phenotypic selection from the original genomic RNA populations of HIV-1 strains LAI and MN (NM) by peripheral blood mononuclear cell culture, B-cell-line propagation and T-cell-line adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Functional characterization of the V1V2 region of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Sequence variation within the human immunodeficiency virus V3 loop at seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the amsterdam population.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Assessment of HIV-1 antigenic diversification using serum as sample source

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Change in tropism upon immune escape by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Relation of phenotype evolution of HIV-1 to envelope V2 configuration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

The role of the humoral immune response in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Why do we not have an HIV vaccine and how can we make one? .

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Development of HIV-1 group-specific neutralizing antibodies after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Crystal structure of SIV matrix antigen and implications for virus assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Biologic features of HIV-1 that correlate with virulence in the host

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Chemokines, lymphocytes, and HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

HIV-1 tropism and co-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900126-6

7 January 2021

10.1016/S0165-2478(98)00126-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10065629%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference